You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA119
  • Published:  28 February 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public

  • Fludarabine for chronic lymphocytic leukaemia (PDF 85 KB)

    Published:
    28 February 2007
  • Gwybodaeth i'r cyhoedd (Word 238 KB)

    Published:
    26 October 2009